Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Immunobiology. 2009;214(9-10):761-77. doi: 10.1016/j.imbio.2009.06.014. Epub 2009 Jul 17.

Cellular and molecular pathways linking inflammation and cancer.

Author information

  • 1DISCAFF, University of Piemonte Orientale A. Avogadro, Novara, Italy. chiara.porta@humanitas.it

Abstract

Several experimental and epidemiological evidence indicate that, irrespective of the trigger for the development (chronic infection/inflammation or genetic alteration), a "smouldering" inflammation is associated with the most of, if not all, tumours and supports their progression. Several evidence have highlighted that tumours promote a constant influx of myelomonocytic cells that express inflammatory mediators supporting pro-tumoral functions. Myelomonocytic cells are key orchestrators of cancer-related inflammation associated with proliferation and survival of malignant cells, subversion of adaptive immune response, angiogenesis, stroma remodelling and metastasis formation. Although the connection between inflammation and cancer is unequivocal the mechanistic basis of such association are largely unknown. Recent advances in the understanding of the cellular and molecular pathways involved in cancer-related inflammation as well as their potential relevance as diagnostic, prognostic and therapeutic targets are herein discussed.

PMID:
19616341
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk